TipRanks
Xspray Pharma AB (DE:6XP)
FRANKFURT:6XP
Germany Market
6XP
Xspray Pharma AB
RESEARCH TOOLSreports

Xspray Pharma AB (6XP) Stock News & Sentiment

2 Followers
Xspray Pharma Targets Q4 2026 FDA Resubmissions for Dasynoc and Nilopki
Premium
Company Announcements
Xspray Pharma Targets Q4 2026 FDA Resubmissions for Dasynoc and Nilopki
21m ago
Xspray Pharma Highlights CML Data Differentiating Dasynoc and Nilopki
Premium
Company Announcements
Xspray Pharma Highlights CML Data Differentiating Dasynoc and Nilopki
9d ago
Xspray Pharma to Showcase Commercial Oncology Strategy at Gothenburg Investor Update
Premium
Company Announcements
Xspray Pharma to Showcase Commercial Oncology Strategy at Gothenburg Investor Update
17d ago
Xspray Pharma to Hold Investor Update Alongside Key Leukemia Conference
Premium
Company Announcements
Xspray Pharma to Hold Investor Update Alongside Key Leukemia Conference
17d ago
Xspray Pharma Schedules Call After FDA Response on Lead Cancer Drug Dasynoc
Premium
Company Announcements
Xspray Pharma Schedules Call After FDA Response on Lead Cancer Drug Dasynoc
1M ago
Xspray Pharma Gets FDA Complete Response Letter on Dasynoc, Speeds Manufacturing for 2026 Resubmission
Premium
Company Announcements
Xspray Pharma Gets FDA Complete Response Letter on Dasynoc, Speeds Manufacturing for 2026 Resubmission
1M ago
Xspray Pharma Bolsters Finances as FDA Decisions Loom for Nilopki and Dasynoc
Premium
Company Announcements
Xspray Pharma Bolsters Finances as FDA Decisions Loom for Nilopki and Dasynoc
2M ago
More DE:6XP News >

6XP News on the Web

Xspray Pharma Highlights CML Data Differentiating Dasynoc and Nilopki
TipRanks News
Bullish
Xspray Pharma Gets FDA Complete Response Letter on Dasynoc, Speeds Manufacturing for 2026 Resubmission
TipRanks News
Bearish
Xspray Pharma Bolsters Finances as FDA Decisions Loom for Nilopki and Dasynoc
TipRanks News
Neutral
Xspray Pharma Schedules Investor Call After FDA Letter on Nilopki
TipRanks News
Bearish
Xspray Pharma Hit by FDA Setback on Nilopki but Keeps HyNap Strategy on Track
TipRanks News
Bearish
Xspray Pharma Staff Fully Take Up Warrants as Key U.S. Oncology Launches Near
TipRanks News
Bullish
Xspray Pharma Narrows 2025 Loss as FDA Sets Review Date for XS003
TipRanks News
Neutral
Xspray Pharma Achieves Key Milestones in Q3 2025
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:6XP’s Media Buzz Sentiment?
Currently, no data Available
What is DE:6XP’s weekly average amount of articles?
In an average week, 0.75 articles about DE:6XP are published.
    What is DE:6XP’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    HUMHumana
    ACETAdicet Bio
    ZYMEZymeworks
    RHHBYRoche Holding
    QTTBQ32 Bio
    Showing the stocks with the most bullish news sentiment over the past week